Ledger.Open graph →
SEC Form D · Amendment · filed December 31, 2014

PRIME GENOMICS, INC

Offering
$1.2M
Sold
$804K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Kevin D. Bastien · Saint Louis, MOExecRobert L. Thomas · London, United KingdomDirectorKirk Galiani · McLean, VAPromoterMarita A. Wein · Grand Cayman, Cayman IslandsExec · Director · PromoterAlan R. Brimm · SAN FRANCISCO, CAPromoterScott R. Greenstone · MILL VALLEY, CADirectorTimothy Roche · San Diego, CAPromoterMatthew A. Sharp · Old Lyme, CTPromoterLancaster Investment Management LLP · London, United KingdomDirectorRobert R. Tufts · SAN FRANCISCO, CADirector · PromoterJames A. Tricarico, Jr · Saint Louis, MOExec · Director · PromoterSandy C. Shaw · SAN FRANCISCO, CAExec · Director · PromoterMark D. Fisher · McLean, VAPromoterRaymond C. Merritt · Berwyn Heights, MDDirector · PromoterPenelope L. Pennington · Saint Louis, MOExecThomas W. Loker · SAN FRANCISCO, CAExecMichael P. Neely · New York, NYDirector · PromoterPeter V. Groetzinger · SAN FRANCISCO, CAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗